Cytos new anti-hypertension vaccine shown successful in trials
Forbes - ZURICH (Thomson Financial) - A prototype anti-hypertension vaccine developed by Switzerland’s Cytos Biotechnology AG showed encouraging results in a trial among a small group of volunteers, according to an article to be published in Saturday’s …
